A scarcity of dobutamine is starting to hit home for cardiologists, surgeons, and patients around the United States, catching some hospitals off guard despite warnings for months that supplies were ...

Study Question: What is the effect of a short-term intravenous infusion of levosimendan or dobutamine on long-term survival in acute decompensated heart failure (ADHF)? Methods: The Survival of ...

Please provide your email address to receive an email when new articles are posted on . Among patients with cardiogenic shock, there was no difference between the inotropic agents milrinone and ...

Zurich, Switzerland The novel calcium sensitizer levosimendan improved hemodynamic performance and lowered short-term mortality more than dobutamine, in patients with severe, low-output heart failure ...

Please provide your email address to receive an email when new articles are posted on . In the CAPITAL Do-Re-Mi trial, there was no difference in outcomes in patients treated with the widely used ...

Against expectations, critically ill people in cardiogenic shock fared similarly receiving one widely used inotrope or another in the small DOREMI trial. Patients had the same clinical outcomes on ...

Review the side-effects of Dobutamine as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

A study in the Journal of Critical Care aimed to characterize the cardiovascular responses to dobutamine in patients with septic shock, according to MDLinx. The hypotheses surrounding the experiment ...

Dobutamine (Dobustat (20 ml)) is a sympathomimetic compound used in the treatment of heart failure and cardiogenic shock. It stimulates the heart muscle. The information provided on this page is ...

WASHINGTON, DC—Two trials evaluating ways to intervene in the narrow therapeutic window after PCI but before signs surface of cardiogenic shock missed their primary endpoints but hinted at the ...